Open AccessA study on Evaluation of efficacy of bethanechol in the management of chemoradiation-induced xerostomia in oral cancer patients
Author(s) -
M Kavitha,
Mubeen Khan,
K Vijayalakshmi
Publication year - 2017
Publication title -
journal of oral and maxillofacial pathology/journal of oral and maxillofacial pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.455
H-Index - 25
eISSN - 1998-393X
pISSN - 0973-029X
DOI - 10.4103/jomfp.jomfp_72_16
Subject(s) - bethanechol , medicine , saliva , placebo , adverse effect , concomitant , cancer , gastroenterology , pathology , alternative medicine , muscarinic acetylcholine receptor , receptor
Squamous cell carcinoma is the most common oral cancer. Radiotherapy with concomitant chemotherapy is an ideal treatment modality largely used for oral cancers, which precipitates many side effects, of which the most challenging and debilitating side effect is xerostomia. This study aimed to evaluate the efficacy of bethanechol in patients with xerostomia following chemoradiation therapy for oral cancer.